1. Malaysia Stocks

  2. •

    Healthcare

  3. •

    Medical - Care Facilities
IHH Healthcare Berhad

IHH Healthcare Berhad

5225.KL
IHH Healthcare BerhadMY flagMalaysian Stock Exchange
8.32
MYR
-0.06
- -
73.52BMarket Cap
IHH Healthcare Berhad
5225.KL
(Malaysian Stock Exchange)

Recent

price

8.32

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
0.56
0.55
1
0.83
0.9
1.03
1.22
1.35
1.39
1.7
1.53
1.95
2.04
2.38
2.77
2.92
2.94
Revenue per Share
0.01
0.06
0.11
0.08
0.09
0.11
0.07
0.12
0.08
0.06
0.03
0.21
0.18
0.34
0.3
0.24
0.24
Basic EPS, GAAP
0.03
0.03
0.06
0.07
0.09
0.07
-0.04
0.09
0.1
0.16
0.18
0.28
0.22
0.21
0.12
0.21
0.22
Free Cash Flow per Basic Share
- -
- -
- -
- -
0.02
0.03
0.03
0.03
0.03
0.03
0.04
0.04
0.06
0.2
0.1
0.11
0.05
Dividend per Share
0.35
0.95
1.31
1.21
1.28
1.36
1.4
2.48
2.85
2.72
2.7
2.88
2.99
3.13
3.34
3.48
3.48
Book Value per Share
-0.61
0.5
1.07
0.95
1.09
1.18
1.12
1.44
1.6
1.53
1.47
1.49
1.5
1.71
1.59
1.66
1.59
Tangible Book Value per Share
8,053
6,108
6,975
8,114
8,165
8,210
8,229
8,236
8,289
8,772
8,776
8,782
8,803
8,807
8,808
8,828
8,836
Basic Weighted Avg Shares
4,507
3,329
6,962
6,756
7,344
8,455
10,022
11,143
11,521
14,912
13,405
17,132
17,989
20,935
24,383
25,745
26,004
Sales/Revenue/Turnover
8.06
14.02
17
17
18.18
18.07
13.86
16.2
13.09
12.09
10.16
18.33
14.95
20.3
15.99
15.19
15.21
Operating Margin (%)
102
221
509
601
608
690
800
978
939
1,355
1,397
1,317
1,407
1,512
1,734
1,911
1,931
Depreciation Expense
79
373
751
631
754
934
612
970
628
551
289
1,863
1,548
2,952
2,657
2,101
2,115
Net Income, GAAP
64.83
19.75
18.75
16.75
22.76
13.59
30.72
28.74
34.9
50.63
63.73
14.84
25.8
16.25
15.81
23.95
26.97
Effective Tax Rate (%)
1.75
11.22
10.78
9.34
10.27
11.04
6.11
8.7
5.45
3.7
2.16
10.87
8.61
14.1
10.9
8.16
8.13
Profit Margin (%)
-2,847
1,291
837
1,558
1,383
1,414
957
4,119
5,018
2,277
1,731
2,484
1,024
-743
-2,705
-4,737
-4,792
Working Capital
6,536
6,183
3,501
4,170
3,593
6,323
6,853
6,948
9,366
10,118
10,369
9,393
8,974
8,064
10,894
9,689
9,320
LT Debt
3,131
11,025
19,176
19,923
21,313
24,237
23,893
25,901
28,352
28,094
27,035
27,277
29,159
32,359
33,908
34,101
33,436
Total Equity
2.07
2.75
4.75
4.02
4.11
4.64
3.06
3.92
2.68
2.26
1.26
6.91
5.06
8.61
7.22
6.06
5.84
Return on Invested Capital (%)
2.35
3.69
5.56
4.02
4.03
5.22
3.68
5.15
2.78
2.25
1.4
4.98
4.56
7.63
6.34
4.82
4.71
Return on Capital (%)
5.66
8.69
10.05
6.67
7.45
8.66
5.41
6.08
2.85
2.32
1.21
7.6
6
10.96
9.33
6.99
7.02
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
3,079
5,850
5,834
LT Borrowings
10,799
7,734
7,452
LT Finance Leases
1,598
1,955
1,868
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
8,836
8,836
8,836
Market Capitalization
66,596
77,254
79,347

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
6,659
6,657
6,799
Cash, Cash Equivalents & STI
2,152
2,287
2,335
Accounts Receivable, Net
3,591
2,861
3,387
Inventories
788
799
890
Total Current Liabilities
8,657
11,394
11,591
Payables & Accruals
- -
- -
- -
ST Debt
3,079
5,850
5,834
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
3.59%
4.82%
0.57%
Free Cash Flow
-31.06%
14.21%
81.36%
Net Income, GAAP
51.65%
117.52%
-20.93%
Sales/Revenue/Turnover
12.37%
14.25%
5.59%
Total Cash Common Dividend
28.06%
48.11%
5.22%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
5,955
6,093
5,643
6,692
24,383
2025
6,294
6,298
6,570
6,583
25,745
2026
6,553
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.09
0.07
0.06
0.08
0.3
2025
0.06
- -
0.07
0.06
0.24
2026
0.06
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
0.05
0.1
2025
- -
- -
- -
0.05
0.11
2026
- -
- -
- -
- -
- -
Similar Companies
Clariane SE (CLARI.PA)
Thonburi Healthcare Group Public Company Limited (THG.BK)
Etao International Co., Ltd. (ETAOF)
Chiang Mai Ram Medical Business Public Company Limited (CMR.BK)
Good Fellow Healthcare Holdings Limited (8143.HK)
Fortis Healthcare Limited (FORTIS.BO)
Business
IHH Healthcare Berhad (IHH Healthcare) operates as one of the world's largest private healthcare groups, delivering a comprehensive portfolio of integrated healthcare services from primary to quaternary care; ancillary services including diagnostic laboratories, imaging centers, ambulatory care, rehabilitation, medical education, and hospital project management; and specialized treatments across cardiology, oncology, orthopedics, gastroenterology, urology, spine surgery, haematology, and stem cell transplantation. The company manages over 80 hospitals under prestigious brands such as Parkway, Pantai, Gleneagles, Mount Elizabeth, Prince Court, Fortis, Acibadem, and Timberland Medical Centre, serving millions of patients annually through its network supported by more than 70,000 employees. Headquartered in Kuala Lumpur, Malaysia, and listed on Bursa Malaysia (5225.KL) and the Singapore Exchange, IHH Healthcare maintains a global footprint spanning 10 countries including key markets in Malaysia, Singapore, Türkiye, India, Greater China (including Hong Kong), and extending to the Netherlands, with operations structured around major subsidiaries Parkway Pantai and Acibadem Healthcare Group. The group targets diverse customer segments encompassing local populations, medical tourists from regions such as the Middle East, Central Asia, Eastern Europe, and Borneo, as well as public-private partnerships with entities like Malaysia's Ministry of Health for capacity building and community programs. Incorporated in 2010 with roots tracing to acquisitions in the 1970s, IHH Healthcare has pursued aggressive inorganic growth, including the 2024 acquisitions of Timberland Medical Centre (82 beds in Kuching, Sarawak, with plans for a 200-bed expansion) for RM245 million and Island Hospital (600 beds in Penang) for RM3.9 billion, bringing its Malaysian hospital count to 18; the 2023-2024 acquisition of Kent Health Group in Türkiye and increase of its stake in Gleneagles Healthcare India to 98.17%; and the 2025 finalization of a majority stake in Fortis Healthcare (increasing indirect ownership to 31.17% via open offer and preferential allotment) alongside Shrimann Superspeciality Hospital and Bayındır Healthcare Group (adding three hospitals and six dental clinics in Türkiye under the Acıbadem-Bayındır brand). These strategic moves align with a broader expansion plan targeting 4,000 additional beds by 2028 through brownfield projects, facility upgrades like Singapore's Mount Elizabeth Hospital Project Renaissance, and new specialized centers, enhancing market share in high-growth geographies and medical tourism hubs.